| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Nov―21 |
Genomic determinants in pathogenicity of SARS-CoV-2 versa common cold coronaviruses |
Zahra Arab-Bafrani, Majid Nikoubin-boroujeni, Saeedeh Ebrahimi, Ali Teimoori, Elham Heidari, Elham Mousavi |
| 2 |
[GO] |
2024―Aug―30 |
The effect of the
MBL2
gene rs1800450 variant on COVID-19 development in Turkish patients |
Mustafa Capraz, Akin Tekcan, Mustafa Cihangiroglu, Ayse Feyda Nursal, Aylin Capraz, Elif Menekse, Hatice Dortok Demir, Nilufer Kuruca, Serbulent Yigit |
| 3 |
[GO] |
2024―Aug―02 |
Association between
ACE
(rs4343 and rs1799752),
AGTR1
(rs5186), and
PAI-1
(rs2227631) polymorphisms in the host and the severity of Covid-19 infection |
Seher Polat, Zühal Özer Şimşek |
| 4 |
[GO] |
2024―May―16 |
Novel synthesis of the first new class of triazine sulfonamide thioglycosides and the evaluation of their anti-tumor and anti-viral activities against human coronavirus |
Reham A. Mohamed-Ezzat, Galal H. Elgemeie |
| 5 |
[GO] |
2024―May―14 |
Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry |
Krzysztof Urbanowicz, Mikolaj Opielka, Kim M. Stegmann, Antje Dickmanns, Matthias Dobbelstein, Godefridus J. Peters, Ryszard T. Smoleński |
| 6 |
[GO] |
2024―Apr―25 |
Study on the correlation between
DPP9
rs2109069 and
IFNAR2
rs2236757 polymorphisms with COVID-19 mortality |
Mahnaz Safari, Rezvan Tavakoli, Mohammadreza Aghasadeghi, Akram Sadat Tabatabaee Bafroee, Abolfazl Fateh, Pooneh Rahimi |
| 7 |
[GO] |
2024―Mar―09 |
The effect of mesenchymal stem cells administration on DNA repair gene expressions in critically ill COVID-19 patients: prospective controlled study |
Nilgün Işıksaçan, Gökhan Adaş, Pınar Kasapoğlu, Zafer Çukurova, Rabia Yılmaz, Kadriye Kurt Yaşar, Duygu Irmak Koyuncu, Fatima Ceren Tuncel, Gülçin Şahingöz Erdal, Asuman Gedikbaşı, Sacide Pehlivan, Erdal Karaoz |
| 8 |
[GO] |
2024―Feb―29 |
New insights into complex formation by SARS-CoV-2 nsp10 and nsp14 |
Céleste Sele, Ewa Krupinska, Anna Andersson Rasmussen, Simon Ekström, Lucas Hultgren, Jiaqi Lou, Frank Kozielski, S. Zoë Fisher, Wolfgang Knecht |
| 9 |
[GO] |
2024―Jan―19 |
HLAB27
may confer protection to COVID-19 in generalized vitiligo patients from South Gujarat population |
Prashant S. Giri, Radhika Bhimani, Naresh C. Laddha, Mitesh Dwivedi |
| 10 |
[GO] |
2023―Oct―03 |
Evaluating interleukin-6 levels and the rs1800795 variant in Turkish patients with COVID-19: a prospective cohort study |
Ozlem Sezer, Ayse Feyda Nursal, Ozgur Gunal, Selim Gorgun, Akin Tekcan, Goksenin Unluguzel Ustun, Serbulent Yigit |
| 11 |
[GO] |
2023―Aug―30 |
Effect of vitamin D receptor gene BsmI polymorphism on hospitalization of SARS-CoV-2 positive patients |
Recai Aci, Adem Keskin, Serbulent Yigit, Ozlem Sezer, Muhammet Taha Kaya |
| 12 |
[GO] |
2023―Mar―28 |
Association of ACE ID, MTHFR C677T, and MIF-173GC variants with the clinical course of COVID-19 patients |
Akın Tekcan, Mustafa Cihangiroglu, Mustafa Capraz, Aylin Capraz, Serbülent Yigit, Ayse Feyda Nursal, Elif Menekse, Zeynep Hülya Durmaz, Hatice Dortok Demir, Burak Ozcelik |
| 13 |
[GO] |
2023―Feb―14 |
The investigation of host genetic variants of toll-like receptor 7 and 8 in COVID-19 |
Gokhan Bagci, Oguz Gundogdu, Ayse Nur Pektas, Binnur Bagci, Onur Avci, Sinan Gursoy, Kenan Kaygusuz, Nazif Elaldi |
| 14 |
[GO] |
2023―Jan―28 |
The effect of DNA repair gene variants on COVID-19 disease: susceptibility, severity, and clinical course |
Naci Senkal, Istemi Serin, Sacide Pehlivan, Mustafa Pehlivan, Alpay Medetalibeyoglu, Timurhan Cebeci, Hilal Konyaoglu, Yasemin Oyacı, Gozde Yesil Sayın, Ummuhan Isoglu-Alkac, Tufan Tukek, Murat Kose |
| 15 |
[GO] |
2022―Dec―06 |
Synthesis of molnupiravir (MK-4482, EIDD-2801): a promising oral drug for the treatment of COVID-19 starting from cytidine |
P. Venkatanarayana, Deepti Kolli, Naresh Varma Seelama, D. S. Ramakrishna |
| 16 |
[GO] |
2022―Dec―06 |
Toll-like receptor-2 (TLR-2) rs111200466 variant offers protection against SARS-CoV-2 infections and mortality: a worldwide epidemiological correlation analysis |
Nisha Nayak, Abhijit Pati, Suraj Kumar Nahak, Surjyapratap Sarangi, Bidyutprabha Pradhan, Sunali Padhi, Aditya K. Panda |
| 17 |
[GO] |
2022―Aug―11 |
In vitro selection of a single-strand DNA aptamer targeting the receptor-binding domain of SARS-CoV-2 spike protein |
Yongjun Chen, Xuefeng Yang, Jian Liu, Dandan Zhang, Jun He, Liang Tang, Jianming Li, Qin Xiang |
| 18 |
[GO] |
2022―Jun―23 |
Synthesis of novel pyridine and pyrimidine thioglycoside phosphoramidates for the treatment of COVID-19 and influenza A viruses |
Mamdouh A. Abu-Zaied, Galal H. Elgemeie, Fathi T. Halaweish, Sherif F. Hammad |
| 19 |
[GO] |
2022―May―09 |
Containing the spread of COVID-19 virus facing to its high mutation rate: approach to intervention using a nonspecific way of blocking its entry into the cells |
Khue Vu Nguyen |
| 20 |
[GO] |
2021―Jul―15 |
Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2 |
Akira Sato, Yoko Ogino, Sei-ichi Tanuma, Fumiaki Uchiumi |
| 21 |
[GO] |
2021―May―13 |
Problems associated with antiviral drugs and vaccines development for COVID-19: approach to intervention using expression vectors via GPI anchor |
Khue Vu Nguyen |
| 22 |
[GO] |
2021―Mar―15 |
COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients |
Duygu Aydemir, Gulcin Dağlıoğlu, Aslihan Candevir, Behice Kurtaran, Sevcan Tan Bozdogan, Tamer Cevat Inal, Nuriye Nuray Ulusu |
